We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00717392
First Posted: July 17, 2008
Last Update Posted: March 1, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Lidia Gabis MD, Sheba Medical Center
  Purpose
Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.

Condition
Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

Resource links provided by NLM:


Further study details as provided by Dr. Lidia Gabis MD, Sheba Medical Center:

Primary Outcome Measures:
  • Improving the parameters of autism [ Time Frame: Repetitive behaviors ]
    Repetitive behaviors Eye contact Communication


Enrollment: 40
Study Start Date: September 2008
Study Completion Date: July 2012
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Hippotherapy_ADHD
10 children with ADHD who receive hippotherapy
Hippotherapy_ASD
10 children with ASD who receive hippotherapy
Control_ADHD
10 children with ADHD who DO NOT receive hippotherapy
Control_ASD
10 children with ASD who DO NOT receive hippotherapy

Detailed Description:

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. Most studies that tested hippotherapy were uncontrolled and focused on motor problems, such as cerebral palsy. Today, hippotherapy is used for various developmental problems such as Attention deficit / Hyperactivity disorder (ADHD) and Autism spectrum disorder (ASD), without clear information about its efficacy for these populations.

The purpose of the current research is to evaluate the efficacy of 6 months of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy for 6 months will show better outcomes than children with the same problems who are not treated with hippotherapy.

Assessment:

  • BRIEF questionnaire
  • Stony Brook Questionnaire

All questionnaires will be applied at the beginning of the study and after 6 months.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hippotherapy subjects will be taken from horseback riding farms. Control subjects will be taken from a tertiary care clinic.
Criteria

Inclusion Criteria:

  • Age: 5-17 years.
  • A diagnosis of ADHD or ASD.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00717392


Locations
Israel
Weinberg Child Development Center, Sheba Medical Center, Tel-Hashomer
Ramat-Gan, Israel
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Lidia Gabis, MD Sheba Medical Center
  More Information

Responsible Party: Dr. Lidia Gabis MD, Director, The Weinberg Child Development Center, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00717392     History of Changes
Other Study ID Numbers: SHEBA-08-5327-LG-CTIL
First Submitted: July 16, 2008
First Posted: July 17, 2008
Last Update Posted: March 1, 2013
Last Verified: February 2013

Keywords provided by Dr. Lidia Gabis MD, Sheba Medical Center:
ADHD
ASD

Additional relevant MeSH terms:
Disease
Attention Deficit Disorder with Hyperactivity
Autism Spectrum Disorder
Developmental Disabilities
Pathologic Processes
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders
Child Development Disorders, Pervasive